Novare Capital Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,507 shares of the healthcare conglomerate's stock after purchasing an additional 7,174 shares during the period. UnitedHealth Group comprises about 1.4% of Novare Capital Management LLC's portfolio, making the stock its 18th largest holding. Novare Capital Management LLC's holdings in UnitedHealth Group were worth $16,693,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Arnhold LLC increased its stake in UnitedHealth Group by 52.3% during the 2nd quarter. Arnhold LLC now owns 73,213 shares of the healthcare conglomerate's stock worth $22,840,000 after buying an additional 25,150 shares in the last quarter. William Blair Investment Management LLC increased its stake in UnitedHealth Group by 9.5% during the 2nd quarter. William Blair Investment Management LLC now owns 684,141 shares of the healthcare conglomerate's stock worth $213,431,000 after buying an additional 59,120 shares in the last quarter. Koshinski Asset Management Inc. increased its stake in UnitedHealth Group by 16.7% during the 2nd quarter. Koshinski Asset Management Inc. now owns 10,825 shares of the healthcare conglomerate's stock worth $3,377,000 after buying an additional 1,546 shares in the last quarter. Citizens Business Bank increased its stake in UnitedHealth Group by 0.9% during the 2nd quarter. Citizens Business Bank now owns 8,368 shares of the healthcare conglomerate's stock worth $2,611,000 after buying an additional 75 shares in the last quarter. Finally, Hoese & Co LLP increased its stake in UnitedHealth Group by 566.7% during the 2nd quarter. Hoese & Co LLP now owns 1,000 shares of the healthcare conglomerate's stock worth $312,000 after buying an additional 850 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Weiss Ratings restated a "sell (d+)" rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. KeyCorp increased their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a research note on Wednesday, October 8th. Cantor Fitzgerald reiterated an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Finally, Zacks Research upgraded shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $385.13.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Down 0.0%
UNH stock opened at $356.53 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a 50 day moving average price of $329.38 and a two-hundred day moving average price of $344.86. The stock has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the firm earned $6.80 earnings per share. The firm's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.